Mycophenolate Mofetil Patent Expiration
Mycophenolate Mofetil was first introduced by Roche Palo Alto Llc
Mycophenolate Mofetil Patents
Given below is the list of patents protecting Mycophenolate Mofetil, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Myhibbin | US11931455 | Pharmaceutical suspension for oral dosage | Aug 16, 2039 | Azurity |
| Myhibbin | US12097284 | Mycophenolate oral suspension | Aug 16, 2039 | Azurity |
| Myhibbin | US12097285 | Mycophenolate oral suspension | Aug 16, 2039 | Azurity |
| Myhibbin | US12194143 | Mycophenolate oral suspension | Aug 16, 2039 | Azurity |
| Myhibbin | US12226526 | Mycophenolate oral suspension | Aug 16, 2039 | Azurity |
| Cellcept | US5688529 | Mycophenolate mofetil high dose oral suspensions |
Nov 18, 2014
(Expired) | Roche Palo |
Mycophenolate Mofetil's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List